Aprepitant in the Management of Immune Checkpoint Inhibitors Pruritus in Solid Cancer Patients

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Aprepitant in the Management of Immune Checkpoint Inhibitors Pruritus in Solid Cancer Patients	Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, skin disorder	Not yet recruiting	Phase 1	2025-04-17		NCT06931119

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Rabin Medical Center	33

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials